4//SEC Filing
Marks Joseph 4
Accession 0001209191-20-054214
CIK 0001769804other
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 6:41 PM ET
Size
6.2 KB
Accession
0001209191-20-054214
Insider Transaction Report
Form 4
Augmedix, Inc.NONE
Marks Joseph
Director
Transactions
- Award
Employee Stock Option (right to buy)
2020-10-05+80,861→ 80,861 totalExercise: $0.65Exp: 2030-04-28→ Common Stock (80,861 underlying)
Footnotes (2)
- [F1]The options will vest as to 1/4 of the total shares on January 8, 2021, and an additional 1/48 of the options will vest monthly thereafter until the options are fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F2]On October 5, 2020, the Issuer's wholly-owned subsidiary, August Acquisition Corp. ("Acquisition Sub"), merged with and into Augmedix, Inc., a privately held Delaware corporation ("Augmedix"). Pursuant to this transaction (the "Merger"), Augmedix was the surviving corporation and became the Issuer's wholly owned subsidiary. All of the outstanding shares of stock of Augmedix held by accredited investors were converted into shares of the Issuer's common stock. All of the outstanding warrants, options and stock appreciation rights of Augmedix were assumed by the Issuer.
Documents
Issuer
Augmedix, Inc.
CIK 0001769804
Entity typeother
Related Parties
1- filerCIK 0001826151
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 6:41 PM ET
- Size
- 6.2 KB